-
The New York Times | Aaron Hernandez, the former New England Patriots tight end and a convicted murderer, was 27 when he committed suicide in April. Yet a posthumous examination of his brain showed he had such a severe form of the degenerative brain disease C.T.E. that the damage was akin to that of players well into their 60s.
Sep 22, 2017
-
STAT | Gene tests are starting to help sort out whether immunotherapy will work for individual cancer patients — or whether it might backfire.
Sep 20, 2017
-
UNMC | Jacob Duncan, a third-year Pharm.D. candidate at the UNMC College of Pharmacy, recently won first place in the national Pharmacy Student Point-of-Care Disease Management Competition at the ninth-annual Next Generation Dx Summit in Washington, D.C.
Sep 19, 2017
-
Diagnostics World Contributed Commentary | After years of alternating centralization and decentralization of diagnostic assays, we are finally entering an era of smart testing in which location is chosen based on what’s best for the patient.
Sep 18, 2017
-
Diagnostics World Video | Diagnostics is a tricky space right now, says Charles Mathews, Vice President of Boston Healthcare. He spends lot of his time focusing on reimbursement and at last month’s Next Generation Dx Summit in Washington, D.C., he outlined some paths around our current payment and reimbursement hurdles.
Sep 14, 2017
-
CNBC |
"This is the moment for digital therapeutics," said Corey McCann, the founder and CEO of Pear Therapeutics.
Sep 14, 2017
-
Diagnostics World Brief | DNAe announced that its CBO, Nick McCooke, presented an update on its first product, the LiDia bloodstream infections (BSI) test, and outlined DNAe’s pipeline of genomic-based tests at BioCentury’s 24th Annual Newsmakers in the Biotech Industry.
Sep 13, 2017
-
Diagnostics World | As the global community brings infection rates down, diagnostics could play a more pivotal role.
Sep 12, 2017
-
Diagnostics World Video | Kevin Hrusovsky, CEO at Quanterix, sees a handheld future for diagnostics. Breast cancer diagnostics at home, concussion diagnostics on the sidelines, Hrusovsky sees a future that is portable and delivers results in real time.
Sep 11, 2017
-
Reuters | A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.
Sep 8, 2017
-
Diagnostics World Contributed Commentary | In the field of biobanking, especially when broad consent is obtained, providing biospecimen-derived research results to participants is a complex and evolving issue. We must remember the context under which these results are generated and that the objectives and responsibilities in the research realm are not the same as in the clinical realm.
Sep 7, 2017
-
Diagnostics World Video | Alex Sbordone, senior advisor, operations, MinuteClinic, CVS Health; and Andrea Vastis, senior manager, pharmacy produce development, patient care programs, CVS Health sit down with Diagnostics World editor Allison Proffitt to discuss point-of-care testing, patient perception, and getting payers on board.
Sep 6, 2017
-
Forbes | If rugby and other sports need a cautionary tale about putting hype over science, they need only remember the disaster that was the biotech start-up Theranos and its promise of quick and easy blood testing.
Sep 1, 2017